Abstract
Norepinephrine (NE) is a well-known appetite regulator, and the nor/adrenergic system is targeted by several anti-obesity drugs. To better understand the circuitry underlying adrenergic appetite control, here we investigated the paraventricular hypothalamic nucleus (PVN), a key brain region that integrates energy signals and receives dense nor/adrenergic input, using a mouse model. We found that PVN NE level increases with signals of energy deficit and decreases with food access. This pattern is recapitulated by the innervating catecholaminergic axon terminals originating from NTSTH-neurons. Optogenetic activation of rostral-NTSTH → PVN projection elicited strong motivation to eat comparable to overnight fasting whereas its inhibition attenuated both fasting-induced & hypoglycemic feeding. We found that NTSTH-axons functionally targeted PVNMC4R-neurons by predominantly inhibiting them, in part, through α1-AR mediated potentiation of GABA release from ARCAgRP presynaptic terminals. Furthermore, glucoprivation suppressed PVNMC4R activity, which was required for hypoglycemic feeding response. These results define an ascending nor/adrenergic circuit, NTSTH → PVNMC4R, that conveys peripheral hunger signals to melanocortin pathway.
Subject terms: Hypothalamus, Neural circuits
Melanocortin pathway’s role in appetite regulation is a well-stablished. Here, authors describe a novel mechanism by which melanocortin pathway is regulated by ascending adrenergic input from brainstem during hunger and hypoglycemia.
Introduction
Obesity is a major public health problem with increasing prevalence over the last few decades1. In addition to reducing overall quality of life, obesity-associated comorbidities constitute a significant burden on overall healthcare system. Ever increasing need for pharmacologic approaches to treat obesity makes it crucial to understand circuits underlying energy homeostasis. Norepinephrine (NE) has long been known to robustly regulate appetite2 and some of the current anti-obesity drugs are thought to recruit nor/adrenergic system as a secondary effect, that may contribute their primary anorexigenic mechanisms3. Understanding nor/adrenergic regulation of appetite is also important to gain insight into the mechanism of how other therapeutics targeting nor/adrenergic system, such as those used for mood disorders, affect appetite and weight gain.
The brainstem is generally known to relay signals of satiety whereas hypothalamic arcuate nucleus (ARC) harbors both hunger promoting and suppressing neurons4–6. The interoceptive information from these regions is integrated in paraventricular hypothalamic nucleus (PVN) and other centers to maintain energy homeostasis. Ablating nor/adrenergic inputs to the PVN, which mainly originates from hindbrain catecholamine neurons, impairs feeding in response to hypoglycemia, suggesting that the brainstem may also convey orexigenic signals7,8. Likewise, direct norepinephrine (NE) injections into the PVN can potently stimulate feeding behavior9. Consistent with an appetite regulating role of nor/adrenergic input to PVN, earlier microdialysis experiments suggested dynamic regulation of PVN NE and epinephrine (E) levels in coordination with energy demands10,11. Further studies using pharmacologic blockers provided initial insights into the intricacies of this nor/adrenergic input; depending on the targeted receptor subtype, where α1 and α2 receptor agonists decreased and increased feeding, respectively12,13. These studies highlight the complexity of NE/E signaling in appetite regulation2. However, due to their limited specificity, mechanisms of how hindbrain catecholamine neurons communicate peripheral signals of energy deficit to modulate appetite remain unresolved. Furthermore, the precise identity of neurons providing feeding relevant NE/E and their downstream effectors in the PVN are poorly understood.
Recently, a subset of NTS (nucleus of the solitary tract) catecholamine neurons were shown to receive vagal input and have the capacity to promote and suppress feeding14–19. Given their extensive projections to the PVN, we hypothesized that catecholaminergic NTS → PVN projections convey energy deprivation signals and modulate appetite. Here, we investigated the role of this circuit in feeding using in vivo fiber photometry recording, optogenetic and chemogenetic behavioral analysis, and ex vivo electrophysiology. We found that PVN NE/E levels and NTSTH (tyrosine hydroxylase) neuronal input to PVN are rapidly modulated by feeding and hypoglycemia. NTSTH → PVN projections are necessary and sufficient for food deprivation and glucoprivation induced feeding. Lastly, we identified MC4R expressing neurons in the PVN as one of the key targets whose suppression is necessary for glucoprivic appetite. These results reveal a circuit by which visceral information related to energy deficit is conveyed by ascending brainstem fibers and integrated within the hypothalamic melanocortin pathway during fasting-induced feeding and glucose counterregulation.
Results
Dynamic modulation of PVN nor/epinephrine levels by feeding and glucoprivation
To gain insight into the role of PVN catecholamine signaling in appetite regulation, we measured NE/E release during feeding with sub-second temporal resolution using the fluorescent GRABNE sensor20 (Fig. 1a). Cre-dependent AAV-DIO-GRABNE2h and an optical fiber were targeted to the PVN of Sim1-cre mice for selective measurement of NE/E release onto PVN neurons (Fig. 1b, c). In fasted mice, presentation of chow food, but not an inedible, known control object (an empty 1.5 ml Eppendorf tube), evoked biphasic NE/E dynamics in the PVN. Food access initially elicited rapid NE/E release followed by a sustained decrease (Fig. 1d–f). The initial rise in NE/E signal was likely mediated by food-related sensory cues since it was also observed in fasted mice given inaccessible food (Supplementary Fig. 1a–d). This response was specific to fasted state since there was no significant difference observed between chow and object presentation in ad libitum fed mice (Supplementary Fig. 1e–h). Chronic fiber photometry recordings revealed that NE/E signal edged toward higher level after 18 h in the absence of food compared to the free feeding state in the same animals (Supplementary Fig. 2a–c). Consistent with a role in appetite regulation, intraperitoneal administration of metabolic signals related to hunger such as ghrelin increased PVN NE/E levels (Fig. 1g, h). A key hallmark of hunger state is increased AgRP neuron activity. Given that much of the hunger state physiology and behavior can be mimicked by artificial activation of AgRP neurons, we asked whether this activity could also lead to increased NE/E release in the PVN. To test this, we expressed hM3Dq activating DREADD in AgRP neurons of Agrp-ires-cre mice in which PVN NE/E levels were simultaneously measured by GRABNE2h sensor. We found that chemogenetic activation of AgRP neurons in sated mice steadily increased PVN NE/E signals (Supplementary Fig. 2g–k), suggesting that hunger-mediated augmentation of nor/adrenergic input to PVN might, in part, be mediated by AgRP neurons.
Based on lesion experiments implicating PVN NE/E signaling in glucoprivic feeding21,22, we next assessed the effect of a 2DG-induced hypoglycemic like state on PVN NE/E levels. Consistently, 2DG-induced glucoprivation evoked robust GRABNE2h signal in the PVN relative to control injection (saline), suggesting NE/E release (Fig. 1g, h). Collectively, these findings are consistent with modulation of intra-PVN NE/E dynamics by energy deficit and feeding.
Activity of NTSTH→PVN projection is modulated by feeding and glucoprivation
We next sought to identify the source of nor/adrenergic input that conveys feeding and hypoglycemia-related information to the PVN. The NTS integrates peripheral signals and broadcasts this information throughout the brain to regulate metabolic homeostasis. Catecholaminergic NTS neurons and their projections to the PVN are implicated in appetite and physiological stress23–26. Alternatively, locus coeruleus (LC) neurons also send abundant NE/E fibers to the hypothalamus and are implicated in satiety27. To determine whether NTS or LC is the source of nutritional state-dependent PVN NE/E signaling, we first targeted AAV-FLEX-tdTomato to these regions of Th-ires-cre mice to visualize projections in the PVN (Fig. 2a). TH immunostaining confirmed tdTomato expression specifically in catecholaminergic neuron soma (Fig. 2b and Supplementary Fig. 3a). Robust NTSTH innervation throughout the PVN confirmed earlier studies and provides a neuroanatomical basis for this connection whereas LCTH axons had sparse labeling in the PVN; therefore, we focused on NTS projections (Fig. 2c and Supplementary Fig. 3a, b). To assess whether NTSTH → PVN projection conveys feeding and glucoprivation related signals, NTSTH neurons were selectively transduced with Axon-GCaMP6s and an optical fiber was implanted over the PVN to image activity dynamics of this connection in awake behaving mice (Fig. 2d). Consistent with the PVN NE/E release patterns observed with GRABNE2h sensor, presenting food evoked a biphasic NTSTH → PVN response with an initial increase (~10 min) followed by silencing in fasted mice (Fig. 2e–g) but not in free feeding mice (Supplementary Fig. 1i–l), suggesting that NTSTH might be a major source of NE release in the PVN during feeding. Similar to NE/E release, NTSTH → PVN activity also increased with 18 h of fasting (Supplementary Fig. 2d–f).
We previously showed that NTSTH neurons orchestrate glucoprivic feeding, in part, through projections in the ARC14. However, local silencing of these projections did not completely abolish 2DG induced feeding response, suggesting parallel pathways are also recruited. We next tested whether NTSTH → PVN activity is also recruited by hypoglycemia. Induction of a hypoglycemic-like state with 2DG profoundly increased NTSTH → PVN axon activity in awake behaving mice (Fig. 2h–j), consistent with 2DG-induced NE/E release in the PVN. However, unlike NE/E signal, NTSTH → PVN activity briefly dropped below baseline in the first minutes after 2DG injection. Additionally, we noticed that NE/E based GRABNE2h signal slightly precedes NTSTH axonal Ca2+ signal. It is possible that lack of a corresponding drop in NE/E signal and temporal lag between the two signals might be due to adrenergic input from areas other than NTS which may be rapidly activated by 2DG. These findings reveal that NTSTH → PVN axon activity mirrors PVN GRABNE2h signal in response to food and glucoprivation; thus, these fibers might contribute to metabolic state-dependent dynamics in PVN NE/E levels.
NTSTH→PVN activity is sufficient to promote feeding and corticosterone release
Given the metabolic state sensitive dynamics of PVN NE/E release and NTSTH → PVN projection activity, we next asked whether the NTSTH → PVN connection has a causal role on appetite regulation using projection-specific optogenetics. NTSTH neurons were transduced with the excitatory opsin, ChR2-eYFP, and a fiber was placed over the PVN. Optogenetic activation of NTSTH → PVN neurons was validated by high levels of eYFP and cFos colocalization in NTSTH somas and slice recordings (Fig. 3a, e upper panel). Stimulating NTSTH → PVN fibers evoked robust food intake relative to tdTomato injected controls during both light and dark cycles (Fig. 3b, c and Supplementary Fig. 4c). Food intake positively correlated with the number of ChR2 expressing NTSTH neurons and stimulation frequency, which saturated at 10 Hz (Fig. 3d, e). Consistent with increased consumption during NTSTH → PVN stimulation, mice displayed more entries and spent significantly more time at food area (FA) with a drastic reduction in latency to enter FA (Fig. 3f–i). Notably, activation of this circuit significantly increased the frequency of meal bouts, but not meal size, suggesting a role for this pathway in meal initiation (Supplementary Fig. 4a, b).
Based on recently reported functional heterogeneity along the rostro-caudal NTSTH neurons in regulating feeding15, we selectively targeted rostral NTSTH neurons (rNTSTH) to evaluate whether their projections to PVN is sufficient to promote food intake. We found that optogenetic activation of rNTSTH axons over PVN caused a rapid and strong feeding response (Fig. 3j–m). Notably, latency for first pellet was significantly shorter in rNTSTH compared to stimulating entire NTSTH fibers, consistent with anorexigenic impact of caudal NTSTH (cNTSTH) neurons (Fig. 3n). Furthermore, 30 min activation of rNTSTH → PVN connection was still capable of eliciting significant feeding response even 30 min after stimulation was ceased (Fig. 3o, p), suggesting that continued activity of these neurons is not required and orexigenic drive can linger into post-activation period akin to NPY signaling from ARCAgRP neurons28. Finally, we measured whether rNTSTH activation can also increase motivation to work for food. Using nose poke based progressive ratio task, we found that rNTSTH-induced feeding response was indeed accompanied by increased motivation to acquire food comparable to fasting (Fig. 3q–s). Conversely, activating caudal-NTSTH → PVN connection did not elevate feeding in light phase nor caused feeding suppression in dark phase (Supplementary Fig. 5). Collectively, our results establish an orexigenic role for the rNTSTH → PVN connection.
Based on the critical role for catecholaminergic NTS neurons and the PVN in stress and hypoglycemia response through the HPA axis, we also investigated the effects of NTSTH → PVN circuit in glucose homeostasis. As expected, NTSTH → PVN stimulation increased systemic corticosterone (cort) levels; however, we did not observe a significant change in plasma glucose levels (Supplementary Fig. 4e–g). This confirms that NTSTH neurons are an upstream circuit node in the HPA axis involved in stress response and hypoglycemia counterregulation. Notably, cort release was not required for the feeding effect since systemic administration of glucocorticoid receptor antagonist mifepristone did not affect NTSTH → PVN mediated feeding (Supplementary Fig. 4d); however, we cannot rule out possible contribution of sympathetic activation.
PVN projecting NTSTH neurons partake in fasting induced and hypoglycemic feeding
Based on our in vivo fiber photometry recording results suggesting that fasting and hypoglycemia promote NE/E release from NTSTH axons in the PVN, we next asked whether this projection is required for deprivation- and hypoglycemic-induced hunger. To test this, we employed an intersectional chemogenetic approach to selectively silence the subset of NTSTH neurons that project to the PVN (Fig. 4a). We injected rgAAV-pEF1a-DIO-FLPo into the PVN of Th-ires-cre mice. This vector is retrogradely transported from axon terminals back to soma in NTS and expresses FLPo-recombinase in a Cre-dependent manner in TH+ neurons. A second virus, pAAV-hSyn-fDIO-hM4Di-mCherry, expressing flp-dependent hM4Di was delivered to the NTS (Fig. 4a). Chemogenetic inhibition of NTSTH → PVN neurons significantly attenuated food consumption after 18 h food deprivation, consistent with the recruitment of this pathway during homeostatic hunger (Fig. 4b). Moreover, 2DG-induced food intake was also significantly suppressed, suggesting a role for NTSTH → PVN projections in hypoglycemic hunger (Fig. 4c). These findings reveal the necessity for PVN projecting NTSTH neurons in fasting- and glucoprivation-induced feeding.
Based on the recent finding that catecholaminergic neurons in the rostral and caudal NTS may have opposing effects on appetite, we sought to selectively determine the role of these PVN projecting catecholaminergic NTS subsets in hypoglycemic feeding15. We employed the same intersectional approach as above but with specific targeting of fDIO-hM4Di to rostral or caudal regions of the NTS (Fig. 4d, e and Supplementary Fig. 6). We found that selective inhibition of PVN projecting rostral, but not caudal, NTSTH neurons significantly reduced 2DG-induced food consumption (Fig. 4f, g).
Given our finding that NTSTH → PVN activation increases corticosterone levels, we next asked if this projection contributes to hypoglycemia counterregulation and if this is mediated by rostral or caudal NTSTH neurons. Intraperitoneal injection of 2DG dramatically increased circulating corticosterone, which was attenuated by inhibition of rostral, but not caudal, PVN projecting NTSTH neurons (Fig. 4h). Inhibiting rostral-NTSTH → PVN projection also tended to decrease 2DG-induced rise in blood glucose but did not reach statistical significance (Fig. 4i). Collectively, these results illustrate a key role for PVN projecting rostral NTSTH neurons in feeding and hypoglycemic response.
PVNMC4R neurons are targeted by ascending NTSTH axons
The PVN harbors a diverse set of molecularly defined neuron ensembles involved in feeding, glucose counterregulation, and several other autonomic responses. We next sought to identify how NTSTH input affects PVN neuronal activity. For this, we initially performed channelrhodopsin-2 assisted circuit mapping (CRACM)29 with loose seal recordings followed by single-cell genotyping (Fig. 5a). In acute slices, photostimulating NTSTH axons influenced PVN neuron firing heterogeneously, with many non-responsive neurons and others exhibiting increased or decreased firing rates (Fig. 5b, c). Using pharmacologic inhibition, we found that excitatory NTSTH → PVN connection requires both glutamatergic and nor/adrenergic transmission, whereas inhibitory NTSTH → PVN connection requires both α1 and α2 adrenergic receptors (Supplementary Fig. 7a–h).
To determine the molecular identity of PVN targets, we collected a subset of PVN neurons that were responsive to NTSTH axon photostimulation. Based on the known role of PVNMC4R neurons in appetite regulation30, we gauged for the presence of Mc4r transcript. We found that NTSTH form both excitatory and inhibitory connections with PVNMC4R (Fig. 5d, e). To verify and further characterize a possible NTS → PVNMC4R connection, we generated Dbh-flp::Mc4r-cre double transgenic mice. We next targeted flp-dependent Chrimson and cre-dependent GCaMP8m to the NTS and PVN, respectively, and placed an optical fiber over the PVN (Fig. 5f, g). Fiber photometry recording in awake mice showed that continuous 10 s stimulation of NTSDBH axon terminals in the PVN evoked transient PVNMC4R activation followed by prolonged inhibition (Fig. 5h–j). Consistent with ex vivo recordings, the inhibitory phase of this connection was sensitive to systemic α-adrenergic blockers (Fig. 5k–m).
We next validated this connection ex vivo using NTSDBH → PVNMC4R CRACM. For this, we delivered flp-dependent Chrimson to the NTS and cre-dependent GFP to the PVN (Fig. 5n, o). In agreement with blind electrophysiology recordings and in vivo photometry results, fluorescent targeted cell-attached recordings revealed that NTSDBH heterogeneously effects PVNMC4R activity (Fig. 5p, q). Consistent with recordings from randomly selected PVN neurons, we found that NTSDBH → PVNMC4R connections utilize nor/adrenergic mechanisms. Recordings with pharmacological blockers showed that excitatory NTSDBH → PVNMC4R connection requires glutamatergic and nor/adrenergic transmission, while inhibitory NTSDBH → PVNMC4R connection utilizes α-adrenergic signaling (Supplementary Fig. 7j–o). Collectively, our findings reveal heterogeneous NTSDBH → PVNMC4R connection dynamics in which nor/adrenergic signaling is required for prolonged inhibition.
Nor/adrenergic modulation of ARCAgRP→PVNMC4R connection
Given the sensitivity of NTSDBH → PVNMC4R connection to adrenergic blockers, we performed fluorescence-guided ex vivo patch clamp recordings from MC4R/tdTomato reporter mice to directly interrogate nor/adrenergic modulation of PVNMC4R neurons. Loose seal recordings with synaptic blockers revealed direct heterogenous NE regulation of PVNMC4R activity (Supplementary Fig. 8a, b). However, application of NE with intact synaptic signaling dramatically increased the magnitude of PVNMC4R neuronal response and the number of responsive neurons for both activation and inhibition (Supplementary Fig. 8c). These results suggest that while nor/adrenergic regulation of PVNMC4R neurons can occur directly, this effect and the number of responsive neurons is amplified by indirect modulation of presynaptic release (Supplementary Fig. 8d). Consistent with presynaptic modulation, bath application of NE potentiated inhibitory synaptic input onto PVNMC4R neurons with an overall increase in IPSC frequency in whole-cell voltage clamp recordings (Fig. 6a–c).
A major source of appetite-regulating inhibitory input onto PVNMC4R neurons arrive from hunger-sensitive ARCAgRP neurons. ARCAgRP neurons are responsive to NE31; however, whether their synaptic terminals are directly responsive to NE/E is unknown. Therefore, we next assessed the effect of NE on ARCAgRP → PVN connection with CRACM. For this, we selectively expressed ChR2 in ARCAgRP neurons of Agrp-ires-cre mice and recorded axonal light-evoked synaptic currents from PVN neurons (Fig. 6d). Bath application of NE robustly increased photoevoked eIPSC amplitude suggesting that ARCAgRP → PVN connection can be potentiated by presynaptic nor/adrenergic signaling (Fig. 6e, f). To verify whether NE has a similar effect in vivo, we expressed Axon-GCaMP6s in AgRP neurons and performed fiber photometry recording from ARCAgRP axon terminals in the PVN (Fig. 6g). Intraperitoneal administration of the α1-adrenergic receptor agonist, cirazoline, significantly and reversibly activated ARCAgRP axons in the PVN (Fig. 6h–j). Since PVNMC4R neurons are a major target of ARCAgRP neurons, α1-adrenergic receptor dependent activation of ARCAgRP axon terminals would be expected to suppress PVNMC4R neuron activity. Consistently, fiber photometry recording from Mc4r-cre mice revealed that cirazoline robustly inhibited PVNMC4R neuron activity (Fig. 6k–n). Taken together, these results suggest that medullary nor/adrenergic input gates presynaptic inhibitory tone onto PVNMC4R neurons arriving from ARCAgRP, a key connection previously implicated in feeding behavior30.
PVNMC4R neuronal suppression is necessary for hypoglycemic feeding
Previously, PVNMC4R neurons were shown to be required for daily food intake regulation;30 however, their role in hypoglycemic feeding is not known. Based on our results showing an orexigenic NTSTH → PVN connection (Fig. 3), the importance of NTSTH → PVN in glucoprivic feeding (Fig. 4), and identification of a NTSDBH → PVNMC4R circuit (Fig. 5), we examined the role of PVNMC4R in hypoglycemic feeding. We first monitored whether NE/E is released onto the PVNMC4R neurons during glucoprivation and found that 2DG injection caused a significant increase in GRABNE2h signal from these neurons (Fig. 7a–d). Consistent with an overall inhibitory impact of NE/E on these neurons, monitoring in vivo PVNMC4R activity with GCaMP7s revealed robust suppression by 2DG-induced glucoprivation (Fig. 7e–h). Next, we chemogenetically activated PVNMC4R to assess the necessity of their inhibition in hypoglycemic feeding. We found that simultaneous PVNMC4R activation completely blocked food consumption caused by 2DG (Fig. 7i–k). These results show that PVNMC4R suppression is essential for hypoglycemic hunger.
Discussion
It has been over six decades since Grossman has shown that NE injection into the hypothalamus elicits strong feeding behavior32. Subsequent studies established PVN as a major site for NE action in eliciting feeding, whose magnitude is on par with another well-known orexigenic agent, neuropeptide-Y (NPY)33. However, neither the source/target nor the physiological role of PVN NE/E has been fully understood. Here we show that PVN nor/adrenergic signaling is dynamically regulated by nutritional state. Using the GRABNE2h sensor selectively expressed in PVN neurons, we found that hunger elevates baseline extracellular NE/E levels and food access suppresses it after a short peak. This pattern is mirrored by activity of nor/adrenergic axons arriving from the rostral NTS to PVN. Selective optogenetic activation and chemogenetic inhibition of rostral NTSTH → PVN connection revealed contribution of this pathway to feeding after deprivation and in response to hypoglycemia. Voracious feeding in response to NTSTH → PVN activation also involved strong increase in motivation to obtain food, which was comparable to ARCAgRP stimulation. Consistently, we found ARCAgRP → PVNMC4R connection is potentiated by activation of presynaptic α1-adrenergic receptors on AgRP axon terminals. Collectively these findings suggest that information related to peripheral hunger signals are transmitted by catecholaminergic NTS neurons and integrated in the PVN melanocortin pathway, revealing that the NTSTH → PVNMC4R circuit partake in energy deficit response to food deprivation and hypoglycemia.
Consistent with earlier neuroanatomical studies, we found that NTSTH, but not LCTH, neurons are a major source for NE/E in PVN34,35. We have previously shown that ARC projecting collaterals from these neurons stimulate hypoglycemic feeding, whereas global activation of entire NTSTH neuron population was established to be strongly appetite suppressive14,17,36. The anorexigenic response elicited by these neurons appears to be mediated through projections to DMH and PBN16,17. Contrary to our findings, recent studies have shown that NTSTH projections to PVN are also mildly anorexigenic, at least in rat18,37. However, these studies were focused on A2 adrenergic population in the caudal NTS and likely excluded the rostral C2 group. Indeed, evidence suggests that TH neurons may have opposite effects on appetite depending on their precise location in the NTS15 such that rostral NTSTH neurons (C2) being orexigenic and the caudally located ones (A2) are anorexigenic. Regardless, these studies demonstrate that NTSTH neurons are not a monolithic population and significant functional heterogeneity exists along the rostro-caudal axis.
Functional divergence among rostro-caudal NTSTH neurons and the complex response profile on its PVN targets might reflect multimodal nature of this projection in responding to various stressors26,38. In addition to hypoglycemia, earlier cFos labeling studies showed that NTSTH neurons can be activated by a variety of physiological and psychological stressors. In line with this, several other PVN neuronal populations have been reported to encode multiple behavioral states39. Stress has a complex relation to appetite; while some acute stressors tend to be anorexigenic, others can drive overeating of rewarding food, which is thought to mitigate negative emotions associated with stress, eventually contributing to obesity40–46. Coping with stressful challenge can also be energy demanding and the orexigenic drive by stress activated pathways such as NTSTH → PVN may have adaptive benefits to restore consumed resources. Notably, appetite-promoting effect of rostral-NTSTH → PVN activation is sustained long after the stimulation ceases. The lingering hunger may help ensure replenishment of energy stores lost during the stressful experience especially if feeding was not optimal through the process. Further imaging and functional studies with increased resolution are needed to establish whether the same subsets of NTSTH neurons are recruited by various homeostatic challenges, including hunger, and how this information is conveyed to PVN neurons.
Ablation of hypothalamic nor/adrenergic fibers have long been known to disrupt feeding in response to a specific type of stress: hypoglycemia. While most existing research focuses on the role of VLM47–49, our results suggest that orexigenic response to hypoglycemia strongly recruits dorsal medullary catecholamine neurons as well. Several lines of evidence support involvement of these neurons in hypoglycemic feeding: (1) rapid activation of NTSTH projections to PVN by 2DG administration, (2) optogenetic activation NTSTH → PVN is sufficient to elicit robust feeding response and corticosterone release, (3) chemogenetic inhibition reduces, but does not eliminate, deprivation and 2DG-induced feeding. Collectively these results show that rostral NTSTH neurons are critical for deprivation and counterregulatory responses. It remains to be addressed how the interplay between VLM and NTS catecholamine neurons coordinates hypoglycemic feeding. One possibility is that these parallel and partially redundant circuits might be recruited in response to different levels of hypoglycemic challenge and may have additive effect on counterregulatory feeding. Alternatively, the speed by which these pathways are recruited might differ or different aspects of counterregulatory response are activated by two cell groups. For example, a recent study showed counterregulatory glucagon release to be mediated by ascending VLM input to SONAVP neurons50. Glucose clamp studies can be combined with the axonal fiber photometry recording approach described here to establish how these diverse medullary populations partake in various aspects of counterregulation51.
Notably, PVN NE/E signaling appears to contribute not only to hypoglycemic feeding but also to daily homeostatic hunger. Consistent with earlier microdialysis studies10,11, we found that PVN NE/E levels drop with refeeding after a transient peak, which might be related to arousal. This suggests that prolonged hunger may elevate baseline levels of NE/E in PVN. Indeed, chronic GRABNE2h recording experiments showed slow rise in the ambient NE/E levels in the PVN in the absence of food. Additionally, in line with earlier observations in the ARC52, ghrelin injection caused significant increase in NE/E levels in the PVN. Finally, we found that activation of AgRP neurons caused small but significant increase in PVN NE/E level. Taken together with the observation that NE potentiates GABA release from AgRP terminals, this surprising result suggests presence of a positive feedback loop between AgRP and PVN-projecting NTSTH neurons, activated during hunger.
Our findings suggest that NTSTH neurons are likely to be the source of elevated NE/E in PVN in response to deprivation-related signals. This is also in agreement with the presence of an NTSTH neuronal subset activated by ghrelin14,53. Finally, acute chemogenetic suppression of PVN projecting NTSTH neurons reduced feeding. Interestingly, severing ventral noradrenergic bundle does not reduce daily food intake; on the contrary, these rats become hyperphagic and obese54. This suggests that chronic loss of orexigenic drive from this pathway, but not the intermingled anorexigenic fibers from A2, can be compensated.
Finally, activation of NTSTH → PVN pathway by metabolic cues may not be limited to visceral signals. Given the established role of rostral-NTS in integrating gustatory signals, the initial activation NTSTH → PVN projection might be mediated by cephalic phase signals, which might also be contributed by arousal signals. Indeed, when fasted mice were given inaccessible food, this initial rise in NE/E levels persisted, supporting the possibility of sensory origin. Given its strong orexigenic potential, the subsequent drop in NE/E signal is likely driven by reduced tonic activity in rostral NTSTH input as feeding progresses. Since our recordings focused on the first ~40 min after food access, we may have overlooked satiation-dependent activation of caudal NTSTH neurons, which are implicated in appetite suppression. Further research is warranted to explore how rostral versus caudal NTSTH neurons participate in different phases of feeding.
Although adrenergic blockers abolished NTSTH induced inhibition of PVN neurons, other transmitters might also be involved with different activity patterns imposed on NTSTH axons. Indeed, Marie et al.55 reported normal feeding in dbh deficient mice in response to low dose of insulin whereas at higher doses feeding was impaired, suggesting that lack of NE/E can be partially compensated by other signaling molecules during mild hypoglycemic challenges. One such candidate might be NPY, which is coexpressed by PVN projecting rostral NTSTH neurons. Interestingly, while global NPY knock-out mice show nearly complete loss of hypoglycemic feeding56, selective ablation of NPY from DBH neurons only partially reduced feeding in response to activation of rostral NTSDBH neurons15. Considering the absolute requirement of DBH neurons for hypoglycemic feeding22, these findings indicate that DBH neurons may also recruit NPY signaling from non-DBH neurons. This is consistent with our observation that ARCAgRP synaptic terminals, which also contain NPY57, can be activated by nor/adrenergic signaling. Further support for a role for NPY comes from the long lasting orexigenic effect of NTSTH → PVN stimulation (Fig. 3o), which was previously shown to be mediated by this molecule28.
A limitation of our study is the use of cre/flp driver lines line to access catecholamine neurons. Due to long post-surgery wait time, we cannot rule out the possibility that a small subset of labeled neurons might actually be TH negative in our experiments. However, based on recording and pharmacology experiments, which confirmed requirement of adrenergic transmission, we think that such misexpression is likely to be functionally inconsequential. We also did not directly test whether the NE/E release by NTSTH axons in the PVN increases feeding and inhibits PVNMC4R neurons. Future experiments with NTSTH specific inactivation of NE/E synthesis will help clarify this.
In summary, we identified a circuit organization activated by hunger and hypoglycemia. Thus far, nearly all tested dorsal medullary neuronal subpopulations reduced feeding17,18,58–66. Our results suggest that rostral NTSTH neurons are unique among the neighboring populations and associated with feeding response thereby providing evidence that this region is also a route for orexigenic signals. NTSTH neurons elicited a heterogenous activity pattern in PVNMC4R neurons, with dominant response being inhibition through, in part, facilitation of GABA release from ARCAgRP presynaptic terminals in PVN. Effectively, this organization connects vagal sensory input to the melanocortin pathway through NTS catecholamine neurons and plays an essential role in hypoglycemic feeding. Given its broad activation pattern in response to variety of stressors besides hypoglycemia26,38, NTSTH axons may recruit additional PVN neuronal subpopulations, other than PVNMC4R and the previously described PVNCRH neurons, depending on the physiological challenge. Thus, it will be important to understand how the type and severity of different stressors are encoded in the NTSTH → PVN interoceptive-preautonomic axis with cell-type specific resolution using the strategies described here.
Methods
Animals
Experimental mice were housed on 12-h light and dark cycle at 20–24 °C, and 40–60% humidity, with ad libitum access to standard chow food and water, unless stated otherwise. Recombinase-expressing lines Sim1-cre (Jackson Labs Stock 006395), Th-cre (Jackson Labs Stock 008601), Th-ires-cre67, Agrp-ires-cre (Jackson Labs Stock 012899), ai14 (Jackson Labs Stock 007914), Mc4r-cre (Jackson Labs Stock 030759) and Dbh-flp (Jackson Labs Stock 033952) were back-crossed with C57BL/6 (Jackson Labs Stock 000664) for maintenance. Studies were performed with 6–24-week-old male and female mice, using similar numbers for both sexes in each experiment. Animal care and experimental procedures were approved by University of Iowa Institutional Animal Care and Use Committee (IACUC) and Istanbul Medipol University Animal Care Committee, MEDITAM. Mice welfare and health checks were conducted in accordance with the IACUC guidelines. Sentinel mice cages were periodically screened for pathogens. Mice that displayed unhealthy posture or more than 20% weight loss were removed from the study.
Stereotaxic surgeries
rAAV injections
Stereotaxic surgeries were performed on 6–24-week-old male and female mice. Briefly, mice were anesthetized with 1.5% isoflurane in the stereotaxic instrument (David Kopf instruments, Tujunga-CA). Disinfected scalp was incised to expose skull which was then drilled to obtain a small hole for injection of 150 to 600 nL virus to each side intracranially using a pulled glass pipette (Drummond Scientific, Wiretrol, Broomall-PA) with ~50 µm tip diameter. Viral injections were performed in the NTS (bregma: −7.00 mm, midline: ±0.50 mm, dorsal surface −3.50 mm), rostral NTS (bregma: −6.50 mm, midline: ±0.50 mm, dorsal surface −3.70 mm), caudal NTS (bregma: −8.20 mm, midline: 0 mm, dorsal surface −3.40 mm) and PVN (bregma: −0.75 mm, midline: ±0.25 mm, dorsal surface: −5.0 mm), as 50 nL/min by a micromanipulator (Narishige, East Meadow, NY), allowing 10 min spread time for each injection. Scalp was stitched after removing the pipette and placing the optical fiber. At least 4 to 8 weeks were given for animal recovery and transgene expression before further experiments. Viruses used are listed in Table 1.
Table 1.
Company | Catalog # | Virus name |
---|---|---|
WZ Biosciences | YL003012-AV9 | AAV9-hsyn-DIO-NE2h |
WZ Biosciences | YL003011-AV9 | AAV9-hsyn-NE2h |
Addgene | 28306 | pAAV-FLEX-tdTomato (AAV1) |
Addgene | 112010 | hSynapsin1-FLEX-axon-GCaMP6s (AAV5) |
Addgene | 20298 | pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV5) |
Addgene | 154867 | pAAV-hSyn-fDIO-hM4D(Gi)-mCherry-WPREpA (AAV8) |
Addgene | 87306 | pEF1a-DIO-FLPo-WPRE-hGHpA (Retrograde) |
VVF Zurich | v413-9 | ssAAV-9/2-hSyn1-chl-dFRT-ChrimsonR-tdTomato(rev)-dFRT-WPRE-hGHp(A) |
VVF Zurich | v663-8 | ssAAV-8/2-shortCAG-dlox-jGCaMP8m(rev)-dlox-WPRE-SV40p(A) |
Addgene | 104495 | pGP-AAV-CAG-FLEX-jGCaMP7s-WPRE (AAV1) |
Addgene | 44361 | pAAV-hSyn-DIO-hM3D(Gq)-mCherry (AAV2) |
Addgene | 51502 | AAV pCAG-FLEX-EGFP-WPRE (AAV2) |
Optical fiber placement
Ferrule capped optical fiber (200 µm core diameter, NA = 0.50, ThorLabs, for in vivo optical stimulation; 400 µm core diameter, NA = 0.48, Thorlabs, for fiber photometry) was implanted above the PVN (bregma: −0.75 mm, midline: 0 mm, dorsal surface: −4.8 mm) following viral injections and fixed with dental cement.
In vivo fiber photometry recording and analysis
Free behaving mice were tethered through their ferrule implants to the fiber optic cables (400 μm core, 0.48 NA, bundled fibers, Doric Lenses) using ceramic mating sleeves (Thorlabs) covered with black tubing to prevent light interference. Mice were allowed a day to acclimate to the tethers before the fiber photometry experiments and were tethered at least 30 min before recording. Fiber photometry signal was recorded at 3 Hz sampling rate, using Doric FP Bundle Imager (Doric Lenses). Light intensity for each wavelength at the end of the tip was set to be approximately 30–50 µW. We recorded a baseline of 10–30 min before any interference (i.e., intraperitoneal injection, food presentation etc.) and recorded for at least 30 min after the events. For chronic recording, data was acquired as 5 min at every 30 min. At the end of the experiments, mice were processed for post hoc histological evaluation. We eliminated animals where the viral transgene expression or the fiber tip was off target.
For the analysis, isosbestic signal (405 nm) was fit to the calcium dependent (465 nm) signal using the linear least squares fit using a custom MATLAB script. Then, ΔF/F values were calculated as (F465 nm – fitted F405nm)/(fitted F405nm). To account for the inter-animal differences in signal intensities, z-scores were calculated from these values as (F-µ(baseline))/δ(baseline), where µ and δ are the average and standard deviation of the baseline period, respectively, while F is the signal for the given time.
For in vivo fiber photometry paired photostimulation experiments, data was acquired at 10 Hz, and photostimulation was performed at 10 Hz with 30 ms pulse width, for 10 s, after 2 mins of baseline period using red laser (635 nm, Doric Lenses Inc., Quebec), and at least five times for each animal. For stimulation following antagonist administration, animals were intraperitoneally injected with saline as control or a cocktail of 2 mg/kg yohimbine and 1 mg/kg prazosin 10 min before the first record. After 2 min of baseline recording, photostimulation was performed as 10 x (3 s ON and 5 s OFF, 10 Hz, 30 ms pulse width) and the stim protocol was repeated as a total of 3 times, having 3 mins of recovery time in between. Analysis of photostimulation paired fiber photometry data was performed same as explained with the exception that fitted 405 nm was replaced with baseline average for the ΔF/F calculation.
Behavioral experiments
Food intake
Mice were placed in custom made plexiglass cages with free access to food and water, unless being fasted and were habituated to handling and/or being tethered to optical fibers for 2–3 days. Photostimulation was performed using a 473 nm diode laser (Doric Lenses Inc., Quebec) with 1 s stimulation (10 Hz, 10 ms pulse width) repeated every 4 s, for a total of 2–4 h. Food intake was measured manually every 2 h for baseline, stimulation and post-stimulation periods, or continuously using FED3 pellet dispensers68. For inhibition experiments, mice were fasted for 18 h, and then were injected with saline or CNO (3 mg/kg) and food intake was manually measured for 4 h. In another set of experiments, food intake was also measured after intraperitoneal injection of 2DG (450 mg/kg) with or without CNO (3 mg/kg)/DCZ (0.5 µg/kg) and food intake was measured for up to 6 h manually, or with FED3 pellet dispensers.
For all experiments, daytime measurements were started within 2 h of light onset, while nighttime measurements were started immediately with dark onset, baseline being the dark onset on the previous night. During a subset of the experiments, mice were traced with a CCD camera and the videos were analyzed using Ethovision XT15 software for the time spent in, latency to enter and number of entries to the food area.
For feeding pattern analysis, food intake was monitored continuously using Coulbourn Habitest or FED3 single pellet food delivery systems. A “meal” was defined as 4 or more pellets consumed within 10 min. Mice treated with mifepristone were given an i.p. injection of the drug (5 mg/kg) freshly dissolved in DMSO, before photostimulation.
Progressive ratio task
After mice were acclimated to the use of FED3 devices, the FED3 setting was changed to ‘Fixed Ratio-1’ (FR1) mode, where mice had to poke their noses to one of the poker holes in the device to obtain food, then to FR3 (3 pokes per pellet) and finally to FR5 (5 pokes per pellet), changing the setting each day. Next day the device mode was set to progressive ratio schedule, that delivered chow pellets with a nose poke ratio of 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, etc. (adapted from ref. 69), under ad libitum condition with or without photostimulation, or after overnight fasting. The break point was defined as the number of pellets where animals stopped working for more than 10 min.
Blood glucose and corticosterone measurements
Blood was drawn following a tail snip and either immediately evaluated for blood glucose with CareTouch Blood Glucose Monitoring System or were processed for corticosterone measurement with Alpco Mouse and Rat Corticosterone ELISA kit, as described in the user manual. Blood was drawn 10 min before and 60 min after photostimulation, or 10 min before and 90 min after 2DG and/or DCZ injections.
Electrophysiology
2- to 4-month-old male and female mice were used for ex vivo electrophysiology. Mice deeply anesthetized with isoflurane were decapitated and 300-μm-thick coronal sections were obtained from a vibratome in a chilled 95% O2 and 5% CO2 aerated cutting solution consisting of (in mM): 92 NMDG, 92 HCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO4, and 0.5 CaCl2. Brain sections were incubated for 5 min in the same aerated solution warmed at 33 °C. In the same heated solution, NaCl was added (NaCl concentration in solution 20 μM) and slices were incubated for 5 more minutes. More NaCl was added (final NaCl concentration 50 μM) and sections were incubated an additional 2 min. Brain slices were transferred and incubated for >45 min at room temperature in an aerated solution containing (in mM): 92 NaCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 2 MgSO4, and 2 CaCl2. Slices were placed in a recording chamber perfused with an aerated artificial cerebral spinal fluid solution (aCSF) consisting of (in mM): 124 NaCl, 2.5 KCl, 1.2 NaH2PO4, 24 NaHCO3, 5 HEPES, 12.5 glucose, 2 MgSO4, and 2 CaCl2. Cell-attached and whole-cell patch clamp recordings were performed using electrodes with 5–10 MΩ tip resistances. Pipettes were filled with the same aCSF solution for cell-attached recordings. For whole-cell voltage clamp recordings the internal solution was composed of (in mM): 125 CsCl, 5 NaCl, 10 HEPES, 0.6 EGTA, 10 lidocaine ethyl bromide, 5 Mg-ATP, and 0.4 Na2-GTP. Neurons were randomly selected in the PVN for recordings. PVN neurons expressing GFP or tdTomato were selected for fluorescence guided recordings. Data was acquired with MultiClamp 700B Amplifier (Molecular Devices, San Jose, CA) and analyzed with Axon pCLAMP 11 software (Molecular Devices, San Jose, CA). To activate ChR2 and Chrimson opsins in axons, 470 nm laser stimulation was used with an LED array (Doric Lenses Inc., Quebec) and laser pulses were generated with an AMPI Master-9 Pulse stimulator. For ex vivo optogenetic experiments, a 10 Hz/3 ms pulse width photostimulation protocol was used.
PVN neuron responses to different stimuli were classified as excitatory or inhibitory if firing rate increased or decreases by at least 20% from baseline, respectively. GABAergic signaling was blocked with picrotoxin (10 μM). Glutamatergic signaling was blocked with CNQX (10 μM) and D-AP5 (40 μM). Alpha-adrenergic receptors were blocked with prazosin (2 μM) and yohimbine (2 μM). To determine the effects of nor/adrenergic signaling on PVN neuron activity, 5 min of baseline was recorded before application of NE (10 μM) followed by 10–15 min of continued recording. To identify PVN cell-types influenced by NTSTH axon photostimulation, a subset of cells with consistent responses were collected into the pipette tip by applying suction and processed for single-cell PCR. For ex vivo assessment of NTSDBH → PVNMC4R connection, cell-attached recordings were performed. For ChR2- and Chrimson-assisted circuit mapping, 3–5 sweeps were obtained and neurons with consistent response types were characterized as activated or inhibited. For frequency analysis to test blocker sensitivity, entire 0–10 s (excitatory) and 0–3 or 0–10 s (inhibitory) stimulation period is used to calculate firing rate. Whole-cell IPSC recordings were performed with voltage clamped at −60 mV and the average response to 5 stimulations was calculated for each cell during baseline period and after NE application.
Single-cell rt-PCR
Following electrophysiological recordings, the contents of the cells were aspirated into patch clamp pipettes and the pipette contents were immediately transferred to microtubes containing RNA extraction buffer (PicoPure RNA Extraction Kit, Thermo Fisher Scientific). Total RNA was obtained as described in the user’s manual. First strand cDNA synthesis (RevertAid First Strand cDNA Synthesis Kit, Thermo Fisher Scientific) was followed by PCR in 20 μl reaction buffers, containing 1 μl of the single-cell cDNA and the specific primers for Mc4r mRNA (Forward: 5’-CGCGCTCCAGTACCATAACA-3’, Reverse: 5’-ATGGTCAAGGTAATCGCCCC-3’) and Gapdh mRNA (Forward:5’-GTCGGTGTGAACGGATTT-3, Reverse:5’-ATGTTAGTGGGGTCTCGCTC-3’) were used for amplification in separate reactions. After two rounds of PCR (30 cycles each), products were monitored with 2% agarose gel.
Post hoc analysis
Mice were anesthetized with 1.5% isoflurane and were transcardially perfused with 4% paraformaldehyde (PFA) and decapitated. Extracted brains were further fixed in 4% PFA for 4 h and were preserved in 30% sucrose solution. 75 μm brain sections were collected with a vibratome and were either directly mounted (Fluoroshield™ with DAPI, Sigma) or further processed for staining using anti-TH (1:5000, Abcam, #ab112), anti-cFos (1:5000, Cell signaling, #2250) or anti-mCherry (1:1000, Abcam, #ab167453) primary antibodies, and goat anti-rabbit IgG (H + L) Alexa Flour 488/568 (1:500, Thermo-Fisher) secondary antibodies. Imaging was performed with Olympus slide scanner.
Statistical analysis and reproducibility
The number of mice in each cohort were estimated based on pilot experiments and previously published work14,70. Data distribution was assumed to be normal; however, this was not formally tested. Outlier tests were not performed. Where possible, experiments were repeated with an independent cohort, and results were combined for final analysis. Mice were randomly assigned to groups. Initial planning of experimental groups was not blinded, but where possible, investigators were blinded for the experiment and data analysis. Differences between two groups were tested with two-tailed paired and unpaired Student’s t-tests. Multiple group statistical comparisons were made by one-way ANOVA or two-way repeated measures ANOVA, and corrected p-values, and two-tailed Pearson r and p-values were calculated using GraphPad Prism 9 (GraphPad Software Inc.). n represents mice or neuron numbers as indicated for each experiment. The representative images and recording traces provided in the figures were similar for the n number of repetitions provided in relevant sections. A p-value < 0.05 was considered to be statistically significant.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Supplementary information
Source data
Acknowledgements
This work is supported by NIH to D.A. R01DK126740.
Author contributions
N.S.A. and C.L. performed fiber photometry recording; N.S.A., C.L., and I.A. performed behavioral experiments; N.S.A., I.C., C.L., and I.A. performed surgeries; N.S.A. and C.L. performed data analysis; N.S.A. performed genotyping and RT-PCR and prepared MATLAB code for data acquisition and analysis; D.D. managed mouse handling; C.L., Y.Y., and T.A. performed electrophysiological recordings; H.K., J.R., N.S.A., and F.K.A. performed imaging; H.K., I.A., J.R., N.S.A., C.L., U.S., H.C., M.I.A., and B.Y. contributed to post hoc analysis and provided reagents; N.S.A., prepared figures; D.A., N.S.A., and C.L. conceived experiments; D.A., N.S.A., and C.L. wrote the manuscript.
Peer review
Peer review information
Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Data availability
The data generated in this study are provided in the Source data file. Source data are provided with this paper.
Code availability
Custom MATLAB scripts used for analysis of data is available upon request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Nilufer Sayar-Atasoy, Connor Laule.
Supplementary information
The online version contains supplementary material available at 10.1038/s41467-023-42362-8.
References
- 1.Inoue Y, Qin B, Poti J, Sokol R, Gordon-Larsen P. Epidemiology of obesity in adults: latest trends. Curr. Obes. Rep. 2018;7:276–288. doi: 10.1007/s13679-018-0317-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wellman PJ. Norepinephrine and the control of food intake. Nutrition. 2000;16:837–842. doi: 10.1016/s0899-9007(00)00415-9. [DOI] [PubMed] [Google Scholar]
- 3.Muller TD, Bluher M, Tschop MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat. Rev. Drug Discov. 2022;21:201–223. doi: 10.1038/s41573-021-00337-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cheng W, et al. Hindbrain circuits in the control of eating behaviour and energy balance. Nat. Metab. 2022;4:826–835. doi: 10.1038/s42255-022-00606-9. [DOI] [PubMed] [Google Scholar]
- 5.Alcantara IC, Tapia APM, Aponte Y, Krashes MJ. Acts of appetite: neural circuits governing the appetitive, consummatory, and terminating phases of feeding. Nat. Metab. 2022;4:836–847. doi: 10.1038/s42255-022-00611-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Watts AG, Kanoski SE, Sanchez-Watts G, Langhans W. The physiological control of eating: signals, neurons, and networks. Physiol. Rev. 2022;102:689–813. doi: 10.1152/physrev.00028.2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ritter S, Watts AG, Dinh TT, Sanchez-Watts G, Pedrow C. Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology. 2003;144:1357–1367. doi: 10.1210/en.2002-221076. [DOI] [PubMed] [Google Scholar]
- 8.Ritter S, Dinh TT, Li AJ. Hindbrain catecholamine neurons control multiple glucoregulatory responses. Physiol. Behav. 2006;89:490–500. doi: 10.1016/j.physbeh.2006.05.036. [DOI] [PubMed] [Google Scholar]
- 9.Leibowitz SF, Hammer NJ, Chang K. Feeding behavior induced by central norepinephrine injection is attenuated by discrete lesions in the hypothalamic paraventricular nucleus. Pharmacol. Biochem. Behav. 1983;19:945–950. doi: 10.1016/0091-3057(83)90396-9. [DOI] [PubMed] [Google Scholar]
- 10.Paez X, Stanley BG, Leibowitz SF. Microdialysis analysis of norepinephrine levels in the paraventricular nucleus in association with food intake at dark onset. Brain Res. 1993;606:167–170. doi: 10.1016/0006-8993(93)91586-h. [DOI] [PubMed] [Google Scholar]
- 11.Stanley BG, Schwartz DH, Hernandez L, Hoebel BG, Leibowitz SF. Patterns of extracellular norepinephrine in the paraventricular hypothalamus: relationship to circadian rhythm and deprivation-induced eating behavior. Life Sci. 1989;45:275–282. doi: 10.1016/0024-3205(89)90136-7. [DOI] [PubMed] [Google Scholar]
- 12.Leibowitz SF. Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci. Biobehav. Rev. 1988;12:101–109. doi: 10.1016/s0149-7634(88)80002-2. [DOI] [PubMed] [Google Scholar]
- 13.Wellman PJ, Davies BT, Morien A, McMahon L. Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors. Life Sci. 1993;53:669–679. doi: 10.1016/0024-3205(93)90243-v. [DOI] [PubMed] [Google Scholar]
- 14.Aklan, I. et al. NTS catecholamine neurons mediate hypoglycemic hunger via medial hypothalamic feeding pathways. Cell Metab. 10.1016/j.cmet.2019.11.016 (2019). [DOI] [PMC free article] [PubMed]
- 15.Chen J, et al. A Vagal-NTS neural pathway that stimulates feeding. Curr. Biol. 2020;30:3986–3998 e3985. doi: 10.1016/j.cub.2020.07.084. [DOI] [PubMed] [Google Scholar]
- 16.Tsang AH, Nuzzaci D, Darwish T, Samudrala H, Blouet C. Nutrient sensing in the nucleus of the solitary tract mediates non-aversive suppression of feeding via inhibition of AgRP neurons. Mol. Metab. 2020;42:101070. doi: 10.1016/j.molmet.2020.101070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Roman CW, Derkach VA, Palmiter RD. Genetically and functionally defined NTS to PBN brain circuits mediating anorexia. Nat. Commun. 2016;7:11905. doi: 10.1038/ncomms11905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Murphy, S. et al. Nucleus of the solitary tract A2 neurons control feeding behaviors via projections to the paraventricular hypothalamus. Neuropsychopharmacology10.1038/s41386-022-01448-5 (2022). [DOI] [PMC free article] [PubMed]
- 19.Rinaman L. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation. J. Neurosci. 2003;23:10084–10092. doi: 10.1523/JNEUROSCI.23-31-10084.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Feng J, et al. A genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine. Neuron. 2019;102:745–761.e748. doi: 10.1016/j.neuron.2019.02.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Fraley GS, Ritter S. Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-D-glucose-induced neuropeptide Y and agouti gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. Endocrinology. 2003;144:75–83. doi: 10.1210/en.2002-220659. [DOI] [PubMed] [Google Scholar]
- 22.Ritter S, Bugarith K, Dinh TT. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J. Comp. Neurol. 2001;432:197–216. doi: 10.1002/cne.1097. [DOI] [PubMed] [Google Scholar]
- 23.Myers B, Scheimann JR, Franco-Villanueva A, Herman JP. Ascending mechanisms of stress integration: Implications for brainstem regulation of neuroendocrine and behavioral stress responses. Neurosci. Biobehav. Rev. 2017;74:366–375. doi: 10.1016/j.neubiorev.2016.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Berntson GG, Khalsa SS. Neural Circuits of Interoception. Trends Neurosci. 2021;44:17–28. doi: 10.1016/j.tins.2020.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Rinaman L. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res. 2010;1350:18–34. doi: 10.1016/j.brainres.2010.03.059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rinaman L. Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011;300:R222–R235. doi: 10.1152/ajpregu.00556.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sciolino NR, et al. Natural locus coeruleus dynamics during feeding. Sci. Adv. 2022;8:eabn9134. doi: 10.1126/sciadv.abn9134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Chen, Y. et al. Sustained NPY signaling enables AgRP neurons to drive feeding. Elife8, 10.7554/eLife.46348 (2019). [DOI] [PMC free article] [PubMed]
- 29.Atasoy D, Aponte Y, Su HH, Sternson SM. A FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. J. Neurosci. 2008;28:7025–7030. doi: 10.1523/JNEUROSCI.1954-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Garfield AS, et al. A neural basis for melanocortin-4 receptor-regulated appetite. Nat. Neurosci. 2015;18:863–871. doi: 10.1038/nn.4011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Paeger, L. et al. Antagonistic modulation of NPY/AgRP and POMC neurons in the arcuate nucleus by noradrenalin. Elife6, 10.7554/eLife.25770 (2017). [DOI] [PMC free article] [PubMed]
- 32.Grossman SP. Eating or drinking elicited by direct adrenergic or cholinergic stimulation of hypothalamus. Science. 1960;132:301–302. doi: 10.1126/science.132.3422.301. [DOI] [PubMed] [Google Scholar]
- 33.Leibowitz SF. Paraventricular nucleus: a primary site mediating adrenergic stimulation of feeding and drinking. Pharmacol. Biochem. Behav. 1978;8:163–175. doi: 10.1016/0091-3057(78)90333-7. [DOI] [PubMed] [Google Scholar]
- 34.Cunningham ET, Jr., Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 1988;274:60–76. doi: 10.1002/cne.902740107. [DOI] [PubMed] [Google Scholar]
- 35.Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. 1982;257:275–325. doi: 10.1016/0165-0173(82)90010-8. [DOI] [PubMed] [Google Scholar]
- 36.Kreisler AD, Davis EA, Rinaman L. Differential activation of chemically identified neurons in the caudal nucleus of the solitary tract in non-entrained rats after intake of satiating vs. non-satiating meals. Physiol. Behav. 2014;136:47–54. doi: 10.1016/j.physbeh.2014.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Romano A, et al. Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide. Am. J. Physiol. Endocrinol. Metab. 2013;305:E1266–E1273. doi: 10.1152/ajpendo.00411.2013. [DOI] [PubMed] [Google Scholar]
- 38.Maniscalco JW, Rinaman L. Interoceptive modulation of neuroendocrine, emotional, and hypophagic responses to stress. Physiol. Behav. 2017;176:195–206. doi: 10.1016/j.physbeh.2017.01.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Xu, S. et al. Behavioral state coding by molecularly defined paraventricular hypothalamic cell type ensembles. Science370, 10.1126/science.abb2494 (2020). [DOI] [PubMed]
- 40.Kivimaki, M., Bartolomucci, A. & Kawachi, I. The multiple roles of life stress in metabolic disorders. Nat. Rev. Endocrinol.10.1038/s41574-022-00746-8 (2022). [DOI] [PMC free article] [PubMed]
- 41.Razzoli M, Pearson C, Crow S, Bartolomucci A. Stress, overeating, and obesity: Insights from human studies and preclinical models. Neurosci. Biobehav. Rev. 2017;76:154–162. doi: 10.1016/j.neubiorev.2017.01.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Dallman MF, et al. Chronic stress and obesity: a new view of “comfort food”. Proc. Natl Acad. Sci. USA. 2003;100:11696–11701. doi: 10.1073/pnas.1934666100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Dallman MF. Stress-induced obesity and the emotional nervous system. Trends Endocrinol. Metab. 2010;21:159–165. doi: 10.1016/j.tem.2009.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zhang L, et al. Stress- and diet-induced fat gain is controlled by NPY in catecholaminergic neurons. Mol. Metab. 2014;3:581–591. doi: 10.1016/j.molmet.2014.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ip CK, et al. Amygdala NPY circuits promote the development of accelerated obesity under chronic stress conditions. Cell Metab. 2019;30:111–128 e116. doi: 10.1016/j.cmet.2019.04.001. [DOI] [PubMed] [Google Scholar]
- 46.Antelman SM, Szechtman H. Tail pinch induces eating in sated rats which appears to depend on nigrostriatal dopamine. Science. 1975;189:731–733. doi: 10.1126/science.1154024. [DOI] [PubMed] [Google Scholar]
- 47.Sofia Beas B, et al. A ventrolateral medulla-midline thalamic circuit for hypoglycemic feeding. Nat. Commun. 2020;11:6218. doi: 10.1038/s41467-020-19980-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Li AJ, Wang Q, Ritter S. Selective pharmacogenetic activation of catecholamine subgroups in the ventrolateral medulla elicits key glucoregulatory responses. Endocrinology. 2018;159:341–355. doi: 10.1210/en.2017-00630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ritter S, Li AJ, Wang Q. Hindbrain glucoregulatory mechanisms: Critical role of catecholamine neurons in the ventrolateral medulla. Physiol. Behav. 2019;208:112568. doi: 10.1016/j.physbeh.2019.112568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kim, A. et al. Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes. Elife10, 10.7554/eLife.72919 (2021). [DOI] [PMC free article] [PubMed]
- 51.Jokiaho AJ, Donovan CM, Watts AG. The rate of fall of blood glucose determines the necessity of forebrain-projecting catecholaminergic neurons for male rat sympathoadrenal responses. Diabetes. 2014;63:2854–2865. doi: 10.2337/db13-1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Date Y, et al. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab. 2006;4:323–331. doi: 10.1016/j.cmet.2006.09.004. [DOI] [PubMed] [Google Scholar]
- 53.Cornejo MP, et al. Ghrelin receptor signaling targets segregated clusters of neurons within the nucleus of the solitary tract. Brain Struct. Funct. 2018;223:3133–3147. doi: 10.1007/s00429-018-1682-5. [DOI] [PubMed] [Google Scholar]
- 54.Ahlskog JE, Hoebel BG. Overeating and obesity from damage to a noradrenergic system in the brain. Science. 1973;182:166–169. doi: 10.1126/science.182.4108.166. [DOI] [PubMed] [Google Scholar]
- 55.Ste Marie L, Palmiter RD. Norepinephrine and epinephrine-deficient mice are hyperinsulinemic and have lower blood glucose. Endocrinology. 2003;144:4427–4432. doi: 10.1210/en.2003-0561. [DOI] [PubMed] [Google Scholar]
- 56.Sindelar DK, et al. Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology. 2004;145:3363–3368. doi: 10.1210/en.2003-1727. [DOI] [PubMed] [Google Scholar]
- 57.Atasoy D, et al. A genetically specified connectomics approach applied to long-range feeding regulatory circuits. Nat. Neurosci. 2014;17:1830–1839. doi: 10.1038/nn.3854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Cheng W, et al. Calcitonin receptor neurons in the mouse nucleus tractus solitarius control energy balance via the non-aversive suppression of feeding. Cell Metab. 2020;31:301–312 e305. doi: 10.1016/j.cmet.2019.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.D’Agostino, G. et al. Appetite controlled by a cholecystokinin nucleus of the solitary tract to hypothalamus neurocircuit. Elife5, 10.7554/eLife.12225 (2016). [DOI] [PMC free article] [PubMed]
- 60.D’Agostino G, et al. Nucleus of the solitary tract serotonin 5-HT(2C) receptors modulate food intake. Cell Metab. 2018;28:619–630 e615. doi: 10.1016/j.cmet.2018.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Cheng W, et al. NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity. Nat. Commun. 2021;12:5175. doi: 10.1038/s41467-021-25525-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Dumont C, Li G, Castel J, Luquet S, Gangarossa G. Hindbrain catecholaminergic inputs to the paraventricular thalamus scale feeding and metabolic efficiency in stress-related contexts. J. Physiol. 2022;600:2877–2895. doi: 10.1113/JP282996. [DOI] [PubMed] [Google Scholar]
- 63.Blouet C, Schwartz GJ. Brainstem nutrient sensing in the nucleus of the solitary tract inhibits feeding. Cell Metab. 2012;16:579–587. doi: 10.1016/j.cmet.2012.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Liu J, et al. Enhanced AMPA receptor trafficking mediates the anorexigenic effect of endogenous glucagon-like peptide-1 in the paraventricular hypothalamus. Neuron. 2017;96:897–909.e895. doi: 10.1016/j.neuron.2017.09.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Wu Q, Clark MS, Palmiter RD. Deciphering a neuronal circuit that mediates appetite. Nature. 2012;483:594–597. doi: 10.1038/nature10899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Katsurada K, et al. Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons. Biochem. Biophys. Res. Commun. 2014;451:276–281. doi: 10.1016/j.bbrc.2014.07.116. [DOI] [PubMed] [Google Scholar]
- 67.Lindeberg J, et al. Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus. Genesis. 2004;40:67–73. doi: 10.1002/gene.20065. [DOI] [PubMed] [Google Scholar]
- 68.Matikainen-Ankney, B. A. et al. An open-source device for measuring food intake and operant behavior in rodent home-cages. Elife10, 10.7554/eLife.66173 (2021). [DOI] [PMC free article] [PubMed]
- 69.Richardson NR, Roberts DC. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods. 1996;66:1–11. doi: 10.1016/0165-0270(95)00153-0. [DOI] [PubMed] [Google Scholar]
- 70.Aklan I, et al. Dorsal raphe serotonergic neurons suppress feeding through redundant forebrain circuits. Mol. Metab. 2023;69:101676. doi: 10.1016/j.molmet.2023.101676. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data generated in this study are provided in the Source data file. Source data are provided with this paper.
Custom MATLAB scripts used for analysis of data is available upon request.